Transcript Donors Meeting March 15th , 2007

Influenza A (H1N1)
1|
| 18 July 2015
What is Influenza A (H1N1) ?



Swine Flue: infectious acute respiratory disease of pigs;
Animal to human; Human to human;
Mix of viruses from avian, swine and human seasonal influenza in
pigs influenza virus containing genes from number of sources
(reassortant virus)
Direct or indirect contact with infected persons through:

–
–
–

2|
Droplet transmission
Aerosol transmission
Not through well cooked pork meat;
Transmission efficiency of this virus is substantially
higher than seasonal influenza.
| 18 July 2015
Threat of Pandemic Influenza
Animal Influenza
• Circulating in wild
birds, poultry and pigs
3|
| 18 July 2015
• Infects humans in rare
instances - resulting
from close exposure to
pigs
• If virus evolves into a human
virus it could cause a human
influenza pandemic
Severity of Illness
 Attack rates of 22-33%, but it could be higher in densely
populated areas, which might cause considerable burden.
 Sever illness require hospitalization is 1-2% and increase to 10%
in low resource-settings.
 Case-fatality ratio (<0.5%) in high-resource settings but higher in
low resource settings.
 Susceptible population are: Infants and young children, pregnant
women, immunosuppressed or have chronic conditions such as
cardiovascular disease, asthma, diabetes or tuberculosis
4|
| 18 July 2015
Detection
 Surveillance is important in order to detect initial cases of influenza
 Possible cases of new influenza A (H1N1) to be investigated
– A case or a cluster of cases of unexplained influenza-like illness (ILI) or severe
acute respiratory illness (SARI) and may have any of the following:
• Close contact with a confirmed or probable case of new influenza A (H1N1) virus
infection while the patient was ill and up to 24 hours before the onset of symptoms
• Recent travel to an area with sustained community transmission of new influenza A
(H1N1) within 7 days of onset of symptoms
– Unexplained SARI occurring in one or more health care worker(s) in the same
institution within a 7 day period
– Changes in the epidemiology or mortality associated with the occurrence of ILI or
SARI
– Abnormal absenteeism in a school or workplace setting
– Persistent changes noted in the treatment response or outcome of SARI
5|
| 18 July 2015
Treatment
1.
Based on the severity of the conditions:
–
2.
6|
Antiviral drugs: (Oseltamivir (TAMIFLUE), Zanamivir); antibiotics for the related
conditions . Currently no vaccines for H1N1
Health Authorities have to
1. Conduct enhanced surveillance with full epidemiological description of
cases:
2. Collect specimens and transport/ship to a pre-identified laboratory
within 48 hours for testing;
3. Report probable and confirmed cases in real time to relevant national
authorities and to WHO through national focal points
4. Disseminate key education messages to the community on infection risks
and prevention to promote respiratory etiquette and hand hygiene.
5. Reinforce health systems and the capacity of health workers to assess,
classify and manage respiratory illness (especially pneumonia and
respiratory distress)
| 18 July 2015
Current situation
 As of 15 June, 76 countries have officially reported 35,928 cases
of influenza A(H1N1) infection, including 163 deaths.
 Majority of cases are mild cases but spectrum is broad, evolution
unknown;
 World better prepared than even;
 Increase production of antiviral;
 Development of vaccines is ongoing .
7|
| 18 July 2015
Levels of Pandemic Alert
 Pandemic level raised from 4 to 5 at April 29 (pandemic is
imminent);
 Virus has caused sustained community level outbreaks of
transmission in at least 2 countries in one WHO region (Mexico,
USA);
 Pandemic level raised from 5 to 6 on June 11 (Global Pandemic)
 Virus has caused sustained community level outbreaks of virus
transmission in at least 2 countries of 2 WHO regions
8|
| 18 July 2015
MoH activities
 Up-date pandemic preparedness plan;
 Booster lab capacities, enhance diseases surveillance;
 Public awareness;
 Remain on high alert for unusual outbreaks of Influenza-likedisease
 Policies of social distancing;
 Take measure to stop spread if disease hits;
9|
| 18 July 2015
WHO’s support to PA
 Disseminating material for surveillance;
 Procure supplies for strengthening laboratory
capacities; training for lab technicians;
 Procure Tamiflue and personal protective equipment;
 Technical support to national committees for Influenza
and technical working group  up-date for national
preparedness plan;
 Facilitate coordination with neighboring countries;
10 |
| 18 July 2015
Prevention
 The health impact of an influenza pandemic may be reduced:
1.
Be aware, get information!!
2.
Respiratory etiquette – covering the nose and mouth when coughing or sneezing.
3.
Separation/social distancing* – reduce time spent in crowded settings and gatherings,
especially for high risk groups for severe disease such as infants and young children,
pregnant women, and those with underlying chronic conditions such as
immunosuppression, HIV/AIDS, tuberculosis or lung disease or asthma, heart disease, and
diabetes.
4.
Household ventilation – keep households well ventilated.
5.
Hand hygiene – frequent washing of the hands.
 *Explosive outbreaks may be prevented by early school closure, class
dismissal or prevention of mass gatherings.
11 |
| 18 July 2015
What Can Individual Do?
 The vast majority of patients will have mild to moderate disease
and can be managed at home with simple supportive care:
– The key components are bed rest, fluids, good nutrition and use of
antipyretics such as paracetamol for fever
 All patients with acute respiratory infection should avoid close
contact with others for 7 days after onset of symptoms or for 24
hours after resolution of symptoms
 practise respiratory etiquette
 ensure proper hand hygiene
 Stay at home and avoid close contact with uninfected people,
especially high-risk groups, as much as possible.
12 |
| 18 July 2015
What can individual do??
 One caregiver, preferably a family member not in a high-risk
group. The caregiver should:
– Cover nose and mouth when in close contact (closer than 1 m) of the
patient and perform frequent hand hygiene
– Limit close contact with other people as much as possible, especially highrisk groups
– Facilitate air circulation
– Wash clothes, bed-linen and scarves that have been in contact with the
patient's respiratory secretions or stools, with soap and water
– Dispose of used masks properly in a sealed bag
 Patients and caregivers should be supplied with and trained to
wear and dispose of masks.
13 |
| 18 July 2015
What Can Individual Do???
 If the patient’s condition deteriorates → health-care facility.
 All patients should be encouraged to seek prompt care if signs of
severe disease develop. those in high risk groups should seek care
at health facilities as soon as symptoms of ILI develop.
 In low-resource settings, it is routinely encouraged that care is
sought promptly for children less than five years of age in order
to reduce mortality from other life-threatening common illnesses
whose early symptoms may be indistinguishable from those of
influenza, such as, community-acquired pneumonia and
diarrhoea.
14 |
| 18 July 2015